A carregar...
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
Although adverse effects and glucocorticoid resistance cripple their chronic use, glucocorticoids form the mainstay therapy for acute and chronic inflammatory disorders, and play an important role in treatment protocols of both lymphoid malignancies and as adjuvant to stimulate therapy tolerability...
Na minha lista:
| Publicado no: | Oncoscience |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5043069/ https://ncbi.nlm.nih.gov/pubmed/27713909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncoscience.315 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|